Murphy Gp
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Renal Transplantation Outcomes and Treatments 28
-
- Prostate Cancer Treatment and Research 29
- Prostate Cancer Diagnosis and Treatment 18
- Renal and Vascular Pathologies 12
- Renal cell carcinoma treatment 12
- Co-authors
- Chu Tm (13 shared papers)Wang Mc (7 shared papers)C. S. Killian (4 shared papers)Lawrence D. Papsidero (4 shared papers)M Kuriyama (4 shared papers)Lawrence J. Emrich (2 shared papers)E A Mirand (28 shared papers)Mark F. Brady (1 shared paper)
- Journals
- Progress in clinical and biological research (1 paper)PubMed (193 papers)
- Partner nations
- United States
In The Last Decade
Murphy Gp
173 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 943
- Transplantation 52
- Urology 70
- Hematology 102
- Oncology 143
Countries citing papers authored by Murphy Gp
This map shows the geographic impact of Murphy Gp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murphy Gp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murphy Gp more than expected).
Fields of papers citing papers by Murphy Gp
This network shows the impact of papers produced by Murphy Gp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murphy Gp. The network helps show where Murphy Gp may publish in the future.
Co-authors
The 25 scholars most cited alongside Murphy Gp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. | 1980 | 227 |
| 2 | Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. | 1985 | 168 |
| 3 | Prognostic factors in patients with advanced stage prostate cancer. | 1985 | 106 |
| 4 | Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. | 1978 | 82 |
| 5 | A solid-phase fluorescent immunoassay for human prostatic acid phosphatase. | 1978 | 69 |
| 6 | National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. | 1977 | 44 |
| 7 | Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop. | 1998 | 43 |
| 8 | Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American college of Surgeons Commission on Cancer. | 1982 | 30 |
| 9 | Renal tumors induced by a single dose of dimethylnitrosamine: morphologic, functional, enzymatic, and hormonal characterizations. | 1966 | 24 |
| 10 | The bacteriology of ileal conduit urine in man. | 1972 | 24 |
| 11 | Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate. | 1975 | 22 |
| 12 | Chemotherapy of advanced prostatic cancer. | 1977 | 22 |
| 13 | Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis. | 1979 | 22 |
| 14 | Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase. | 1980 | 22 |
| 15 | Prostatic carcinoma treated at a categorical center, 1970--1979. | 1975 | 19 |
| 16 | Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia. | 1976 | 19 |
| 17 | Trends in the United States for the management of adenocarcinoma of the rectum. | 1981 | 17 |
| 18 | Prostatic carcinoma treated at categorical center: clinical and pathologic observations. | 1972 | 16 |
| 19 | Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin. | 1975 | 16 |
| 20 | Erythropoietin release associated with Wilms' tumor. | 1967 | 15 |
About Murphy Gp
Murphy Gp is a scholar working on Transplantation, Pulmonary and Respiratory Medicine, Hematology, Nephrology and Surgery, having authored 194 papers that have together received 1.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Renal Transplantation Outcomes and Treatments (28 papers), Erythropoietin and Anemia Treatment (19 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Renal and Vascular Pathologies (12 papers), Organ Transplantation Techniques and Outcomes (12 papers), Renal cell carcinoma treatment (12 papers) and Acute Kidney Injury Research (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (943 citations), Transplantation (52 citations), Urology (70 citations), Hematology (102 citations) and Oncology (143 citations). Murphy Gp has collaborated with scholars based in United States. Frequent co-authors include Chu Tm, Wang Mc, C. S. Killian, Lawrence D. Papsidero, M Kuriyama, Lawrence J. Emrich, E A Mirand, Mark F. Brady, Tsuneo Nishiura and Takashi Shimano. Their work appears in journals such as Progress in clinical and biological research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.